Germany approves first human trials for vaccine
A clinical test of a Covid-19 vaccine has been approved in Germany, the country’s Federal Institute for Vaccines has said.
In the first part of the trial, 200 healthy people between 18 and 55 will receive several variants of the vaccine as scientists examine its efficacy in providing immunity against the virus..
The vaccine candidate was produced by biotech firm BioNTech, and is an RNA vaccine.
Additional tests will be conducted on more people, including those at higher risk from the disease, in a second stage.
BioNTech said it was developing the vaccine candidate, named BNT162, together with pharmaceutical giant Pfizer.
BNT162 is also set to be trialled in the US, once regulatory approval for testing on humans had been secured there.
Read more via The Independent
